COMPANY PROFILE

WhiteSwell

Explore full profile

Pioneering a new treatment paradigm for acute decompensated heart failure by leveraging the lymphatic system.

Galway, IrelandFounded 2014Biotech & Life Sciences

Valuation $100–250M Last recorded · 2018

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About WhiteSwell

WhiteSwell is a clinical-stage medtech company pioneering a new treatment paradigm for acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits. The company is advancing a minimally invasive catheter-based approach designed to more efficiently remove excess interstitial fluid in patients with ADHF by enhancing the natural fluid removal process of the lymphatic system. For more information visit www.whiteswell.com.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2014
Headquarters: Galway, Ireland
Employees: 32
Open positions: None listed
Dealroom signal: 65.1/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Health Care Information Technology, Healthcare Services, Biotechnology, Cardiology and cardiovascular, Biotech and Pharma, biotech medtech and e-health, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Feb 2025	$0	—	Enterprise Ireland	—
SERIES B✓Equity / VC	Dec 2018	$30M	$120M	InCube Ventures · RA Capital Management	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

WhiteSwell website traffic

Latest recorded traffic for WhiteSwell is 4.5K monthly website visits, up 309.1% over the last three months. WhiteSwell's team declined 15.8% over the past year.

Latest monthly visits4.5K 3-month web change+309.1% 1-year team growth-15.8%

Monthly website visitsNov 2018–Jun 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CECellProtheraDevelops therapeutic solutions for the regeneration of organs injured by pathology or trauma	Mulhouse, France	Operational	28	$18M	$19M
RTR1 TherapeuticsPharmaceutical therapies targeting neurological, metabolic and infectious conditions	Temecula, United States	Operational
GEGenfitDevelops drugs for the prevention and treatment of cardiometabolic and neurodegenerative diseases	Loos, France	Operational
STStentysCoronary artery bifurcation stenosis treatment developer.	Paris, France	Closed
SPSonic PrecisionMedical device company specializing in development of innovative catheters for ablation treatment of cardiac arrhythmias	Eindhoven, Netherlands	Operational
RMRelevium MedicalDeveloping novel pharmacological hydrogel treatments for chronic pain conditions in urgent need of superior solutions.	Galway, Ireland	Operational
COCorinnovaCorinnova is commercializing a breakthrough technological platform for the treatment of congestive heart failure	Houston, United States	Operational
EMEMOSISDevelops and provides products aim at providing a comprehensive blood tests panel for the bioclinical investigation of thrombosis-induced or thrombosis-complicated diseases	Illkirch, France	Operational